Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,41,1.11 [0.97-1.26],0.125672722886958
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,41,1.05 [1.01-1.09],0.0134999408469289
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,41,1.04 [0.99-1.08],0.0870589973168
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,41,1.68 [1.12-2.54],0.0131856246731901
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,41,0.96 [0.90-1.03],0.214088984312216
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,41,1.27 [0.74-2.17],0.389127551112916
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,41,1.03 [0.98-1.08],0.318221420918084
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,41,0.97 [0.78-1.21],0.781080517085122
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,41,1.17 [1.00-1.38],0.0520485095209522
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,41,1.13 [1.03-1.24],0.0094273140132473
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,41,0.97 [0.86-1.09],0.625520795477346
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,41,1.00 [0.93-1.07],0.925771334019518
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,41,1.07 [1.00-1.14],0.0381425245660934
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",Inverse variance weighted,41,1.00 [0.88-1.12],0.962822676665655
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,41,0.94 [0.88-1.01],0.0896072407097588
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,41,0.98 [0.93-1.02],0.301324957124077
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,41,0.97 [0.93-1.02],0.242784240011046
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,41,0.98 [0.95-1.01],0.249912423325866
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,Inverse variance weighted,41,1.07 [1.01-1.13],0.0303513290020397
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",Inverse variance weighted,41,1.09 [1.02-1.16],0.0116876382269715
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,41,1.00 [0.97-1.03],0.954406883308844
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,41,1.11 [0.97-1.27],0.120344619323598
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,41,1.03 [0.99-1.08],0.128629973435183
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,41,1.03 [0.99-1.08],0.1269095954502
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,41,1.02 [0.99-1.04],0.246637154011085
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,41,1.05 [0.99-1.12],0.106524387819504
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,41,0.95 [0.85-1.05],0.284507167565505
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,41,0.99 [0.95-1.03],0.648581889469426
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,41,0.99 [0.93-1.04],0.619131002908505
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,41,0.89 [0.78-1.02],0.0844371772448717
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,41,0.99 [0.94-1.05],0.778917680746231
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,41,0.97 [0.93-1.02],0.240338358739816
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,41,0.96 [0.92-1.00],0.0826225448139813
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,41,0.94 [0.75-1.18],0.609960355457067
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,41,1.05 [1.00-1.11],0.0663350562814218
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,41,0.89 [0.75-1.07],0.217519377132132
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,41,0.94 [0.81-1.11],0.47966854580361
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,41,1.00 [0.95-1.04],0.868457236470336
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,41,1.14 [1.01-1.29],0.0400808273726753
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,41,1.17 [0.98-1.39],0.0770445201988806
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,41,1.15 [1.03-1.28],0.0100333889564798
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,41,1.02 [0.98-1.07],0.33671520156035
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,41,1.02 [0.98-1.06],0.349170822570805
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,41,1.03 [1.00-1.06],0.0872981149505055
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,41,1.05 [1.00-1.10],0.0591589192943288
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,41,1.04 [0.98-1.10],0.20870442275752
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,41,1.04 [0.94-1.16],0.448291498021671
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,41,1.02 [0.97-1.08],0.387866718624091
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,41,1.02 [0.98-1.06],0.385409309615993
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,41,1.00 [0.91-1.09],0.935718676671335
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,41,1.05 [0.98-1.12],0.180487801281207
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,41,1.05 [0.98-1.13],0.178576429919015
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Gastric ulcer,Inverse variance weighted,41,1.06 [0.97-1.15],0.223666682185281
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,41,1.03 [1.01-1.06],0.0176076522196792
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,41,1.04 [0.97-1.11],0.250572377333421
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,41,1.02 [0.97-1.06],0.459519233975546
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,41,1.09 [0.99-1.20],0.0899644096745176
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,41,1.00 [0.95-1.06],0.952512232409069
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,41,1.03 [0.94-1.14],0.514791678683351
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,41,1.03 [1.01-1.06],0.0186184367739502
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,41,1.04 [0.96-1.13],0.356637242053581
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,41,1.00 [0.96-1.05],0.912305784180409
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,41,1.02 [0.98-1.05],0.351779416299201
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",Inverse variance weighted,41,1.01 [0.98-1.05],0.452065684955522
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,41,1.03 [0.99-1.07],0.200647122999237
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,41,1.00 [0.94-1.07],0.989157017379364
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,41,1.02 [0.99-1.05],0.266695466345385
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,41,1.03 [0.99-1.06],0.106190549515153
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,41,0.97 [0.90-1.05],0.474845552123077
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,41,1.00 [0.95-1.06],0.861972072955439
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,41,1.03 [0.99-1.07],0.166197035745442
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,41,1.01 [0.97-1.06],0.612257220817653
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,41,1.01 [0.95-1.08],0.723707211767578
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,41,1.00 [0.97-1.03],0.919172624310091
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,41,0.99 [0.95-1.04],0.718534335374299
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,41,0.97 [0.89-1.06],0.497512789271038
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,41,0.96 [0.88-1.04],0.29179650379098
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,41,0.87 [0.78-0.97],0.0141333367878512
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,Inverse variance weighted,41,1.01 [0.97-1.05],0.611100602370427
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,41,1.01 [0.98-1.05],0.456698312473923
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,41,1.12 [0.98-1.28],0.082759581333863
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,41,1.00 [0.96-1.04],0.938550451913714
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,41,1.00 [0.97-1.04],0.816784542541775
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,41,1.04 [0.94-1.16],0.437140534993484
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,41,1.03 [0.95-1.13],0.458990700876301
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",Inverse variance weighted,41,1.06 [0.96-1.17],0.257353296480489
